Faculty Member – Michael Parr

Michael Parr, BS, PharmD

Associate Professor

Pharmacy & Therapeutics Service Line
Phone: (501) 686-6220
Fax: (501) 296-1133
Office: Ward Tower, G1000
Email: Parrmichaeld@UAMS.edu

Education & Training

Post-Doctoral Pharmacy Residency Albert B. Chandler Medical Center
University of Kentucky
July, 1980 – June, 1982

Doctor of Pharmacy University of Nebraska Medical
College of Pharmacy
May, 1980

Bachelor of Science University of Nebraska at Omaha
(Biology)
May, 1978

Clinical Practice

Director, Pharmacy and Therapeutics Service Line

Honors & Awards

  • Member, Programming, Innovation & Engagement Committee – University Health-System Consortium, January 2003 to Present
  • Member; Membership Advisory Committee – American Society of Health System Pharmacists, January 2006 to December 2007
  • Member, Pharmacy Executive Committee – University Health-System Consortium, January 2003 to December 2006
  • Member, Public Affairs Committee – Arkansas Pharmacists Association July 2002 to June 2003
  • Chairman, Communication Committee – Novation Purchasing Group, October 2001 to October 2002
  • Member, Communication Committee – Novation Purchasing Group, March 1998 to October 2002
  • Board Member, Arkansas Association of Health-System Pharmacists, 1993 to 2002.
  • President, Arkansas Association of Hospital Pharmacists, 1992.
  • Board Member, Arkansas Pharmacists Association, 1992.
  • President-Elect, Arkansas Association of Hospital Pharmacists, 1991.
  • Outstanding Senior Pharmacy Student, Nebraska Society of Hospital Pharmacists, May, 1980.
  • Outstanding Senior Pharmacy Student, The Rho Chi Society, Alpha Epsilon Chapter, May, 1980.
  • Who’s Who Among Students in American Universities and Colleges, 1979-80.
  • President of the Senior Class, University of Nebraska College of Pharmacy, 1979-80.
  • Vice-President of the Junior Class, University of Nebraska College of Pharmacy, 1978-79.

Memberships

  • Arkansas Pharmacists Association
  • American Society of Health-System Pharmacists
  • American Pharmaceutical Association
  • Rho Chi
  • Kappa Psi Pharmaceutical Fraternity

Publications

(Refereed):

  • Gardner S, and Parr MD. Drug Monograph: Oral HMG-CoA Reductase Inhibitors. University Hospital Consortium; Technology Information Service. 1993
  • Parr MD, McIntyre W, Stevenson LM, Chandler, MHH and Macdonald JS. Pharmacokinetics of Ondansetron in Patients Receiving Cisplatin Therapy. Clin Pharm. 1992; 11:1026-9.
  • Mehta RC, Head LF, Hazrati AM, Parr MD, Rapp RP, and DeLuca PP. Fat Emulsion Particle-size Distribution in Total Nutrient Admixtures. Am J Hosp Pharm. 1992; 49:2749-55.
  • Parr MD, Messino MJ, and McIntyre W. Allogeneic Bone Marrow Transplantation: Procedures and Complication. Am J Hosp Pharm. 1991; 48:127-37.
  • Chandler MHH, Stevenson LM, & Parr MD. Improved Nursing-Phlebotomy-Pharmacy Communications: Evaluation of An Aminoglycoside Monitoring Form. Am J Hosp Pharm. 1989; 46:2508-10.
  • Kolpek JH, Blouin RA, Parr MD. Alterations in Creatinine Production in Cushingnoid Patients. Drug Intell Clin Pharm. 1989; 23: 974-977.
  • Sauer KA, Nowak MM, Coons SJ, Parr MD, McIntyre WJ. Justification and Implementation of a Cancer Center Pharmacy Satellite. Am J Hosp Pharm. 1989;46:1389-1392.
  • Foster TS, Kielar RA, Blouin RA, Parr MD, Barton SD, Perchak GJ, Johnson JB. Effect of Four Dosage Regimens of Methazolamide on Intraocular Pressure. Glaucoma. 1989;11:67-71.
  • Ferretti GA, Ash RC, Brown AT, Parr MD, Romond EF, Lillich TT: Control of Oral Mucositis and Candidiasis After Intensive Chemotherapy/Radiation in Marrow Transplantation. A Prospective, Double Blind Study Involving Chlorhexidine Gluconate. Bone Marrow Transplant. 1988; 3:483-493.
  • Parr MD, Hansen LA, Rapp RP: Cost Comparison of Ceftazidime Versus Tobramycin/Ticarcillin Therapy in Three Hospitals. Drug Intell Clin Pharm. 1988; 8:628-631.
  • Parr MD, Barton SD, Haver VM, Porter WH. Cyclosporine Binding to Medication Administration Sets (Letter). Drug Intell Clin Pharm. 1987; 22:1734.
  • Parr MD, Hansen LA, Bush B, Rapp RP. What is the Cost of An Aminoglycoside Level (Letter). Am J Hosp Pharm. 1987; 6:1312.
  • Kolpek JH, Parr MD, Marshall ML, Flueck JA. Ethchlorvynol Pharmacokinetics During Long-term Administration in a Patient with Hyperlipidemia and Hypothyroidism. Pharmacotherapy. 1986; 6:323-327.
  • Tami JA, Parr MD, Brown S, Thompson JS. Monoclonal Antibody Technology. Am J Hosp Pharm. 1986; 43:2816-2825.
  • Tami JA, Parr MD, and Thompson JS. The Immune System. Am J Hosp Pharm. 1986; 43:2483-93.
  • Parr MD, Hansen LA, Waite WW, Rapp RP. Computer Program for Comparing Total Cost of Intravenous Antibiotic Regimens. Am J Hosp Pharm. 1986; 43:2189-93.
  • Parr MD, Bertch KE, and Rapp RP: Amino Acid Stability and Microbial Growth in Total Parenteral Nutrient Solutions. Am J Hosp Pharm. 1985; 42:2688-9.
  • Parr MD, Waite WW, Hansen LA, and McDaniel PA: Cost Comparison of Seven Antimicrobial Combinations as Empiric Therapy in the Febrile Neutropenic Patient. Am J Hosp Pharm. 1985; 42:2484-8.
  • Parr MD, Record KE, Griffith GL, Zeok JB, and Todd EP: Effect of Enteral Nutrition on Warfarin Therapy. Clin Pharm. 1982, l:274-6.
  • Parr MD, Record KE, Griffith GL, Zeok JB, and Todd EP: Effect of Enteral Nutrition on Warfarin Therapy, (abstract) Am J Hosp Pharm. 1982, 39:1242-3.

(Non-Refereed):

  • Book Review of Organ Transplants: A Patient’s Guide. Am J Hosp Pharm. 1993; 50:1296-7.
  • Parr MD, Doukas M, Drug-Induced Hematologic Disorders. In DiPiro JT, Talbert RL, Hayes PE, Yee GC, Matzke GR, Posey LM: Pharmacotherapy: A Pathophysicologic Approach, Ed. 2. Norwalk, CT, Appleton & Lange. 1993:1475-1486.
  • McIntyre WJ, Parr MD, Infections in the Immunosuppressed Patient. In Herfindal ET, Gourley DR, Hart LL: Clinical Pharmacy and Therapeutics, Ed. 5. Baltimore, Williams and Wilkins. 1992:1248-1260.
  • Parr MD, Transplantation Immunology. In Koeller J, Tami J: Concepts in Immunology and Immunotherapeutics, Ed 1. American Society of Hospital Pharmacy. 1990:289-324
  • Parr MD, Infections in the Immunosuppressed Patient. In Herfindal ET, Gourley DR, Hart LL: Clinical Pharmacy and Therapeutics, Ed. 4. Baltimore, Williams and Wilkins. 1988:843-853.
  • Parr MD, Doukas M, Drug-Induced Hematologic Disorders. In Posey LM, DiPiro JT, Talbert RL, Hayes PE, Yee GC: Pharmacotherapy: A Pathophysicologic Approach, Harvard, MA, Elsevier Science Publishing Co. 1988:1028-1037.
  • Book Review of Immunology, Immunopathology and Immunity. Am J Hosp Pharm. 1988; 7:705.
  • “Proper Care of the Hickman Catheter” (Videotape). Released by Wyeth Laboratories, 1985.
  • “Proper Care of the Hickman Catheter” (Booklet). Published by Wyeth
    Laboratories, 1985.

Curriculum Vitae